Impact of YOGA on the Quality of Life and Well-being of Heart Failure Patients

Recruiting N/A Interventional Study
Chronic Heart Failure
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Supportive Care
Participants needed
66 (estimated)
Sponsor
Assistance Publique - Hôpitaux de Paris · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Heart failure (HF) is a chronic disease that has a strong impact on quality of life and is often accompanied by anxiety and depression symptoms that can contribute to poor treatment compliance. The overall management of heart failure is currently part of the recommendations and, alongside drug therapy and electrical devices that can be proposed, lifestyle changes (diet, physical activity) can help…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patient ≥18 years old * Chronic heart failure patient defined by: Most recent LVEF ≤50% (regardless of measurement method) * Stabilized (last episode of acute heart failure dating back more than a month) in NYHA stage I to III dyspnoea, ambulatory, discharged from hospital for…
Contacts

Lise LEGRAND, Dr

01 42 16 30 74

lise.legrand@aphp.fr

CONTACT

Nicolas VIGNOLLES

01 42 16 30 30

nicolas.vignolles-ext@aphp.fr

CONTACT